Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors
Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors


Agilent Technologies Inc. (NYSE: A) today announced that Hans E. Bishop, president and co-founder of Altos Labs, has stepped down from serving on Agilent’s board of directors.



Bishop joined

LivaNova to Present at the Goldman Sachs Healthcare Conference
LivaNova to Present at the Goldman Sachs Healthcare Conference


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs

Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence:
Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence


Agilent Technologies Inc., (NYSE: A) proudly announces the 8850 Gas Chromatograph (GC) System, a small single-channel GC that combines the legacy of the 6850 GC with the capability and system

QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and

EQS-News: M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
EQS-News: M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
EQS-News: M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
Agilent Announces Cash Dividend of 23.6 Cents per Share: https://unsplash.com/photos/WUehAgqO5hE
Agilent Announces Cash Dividend of 23.6 Cents per Share


Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on July 24, 2024, to all shareholders of record as of the close of

Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference


Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries

Acadia Healthcare to Participate in 2024 Leerink Partners Healthcare Crossroads Conference
Acadia Healthcare to Participate in 2024 Leerink Partners Healthcare Crossroads Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the 2024 Leerink Partners Healthcare Crossroads Conference, May 28 – 30, 2024, at the Omni Barton

Premier’s PINC AI™ and Fortune Name the Nation’s 15 Top Health Systems™
Premier’s PINC AI™ and Fortune Name the Nation’s 15 Top Health Systems™


PINC AI, the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 15 Top Health Systems. The list of recognized health systems for the 16th consecutive year

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend


Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting.



Stockholders ratified the continuation of

Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes


DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM device that easily

Agilent to Participate in Jefferies Global Healthcare ConferencePhoto, wide shot, wide-angle lens, soft focus,  Car rental company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-C39HK7mRtkD4E8dIGhNKdJKJ.png?st=2023-05-14T13%3A30%3A04Z&se=2023-05-14T15%3A30%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T20%3A57%3A44Z&ske=2023-05-14T20%3A57%3A44Z&sks=b&skv=2021-08-06&sig=c7kEiWtHt1KibrlL7jP9uEmEuV%2BuAnv1nRBACXoedSk%3D
Agilent to Participate in Jefferies Global Healthcare Conference


Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City on Wednesday, June 5, at

Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
CenterWell Specialty Pharmacy Wins National Patient Choice Award
CenterWell Specialty Pharmacy Wins National Patient Choice Award


CenterWell Specialty Pharmacy has received the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the sixth time in seven years. The award recognizes best-in-class customer

Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the

EQS-News: Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
EQS-News: Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
EQS-News: Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
Financial year 2023/24: Sonova ends year on improving trajectory after growth picks up in second half
Financial year 2023/24: Sonova ends year on improving trajectory after growth picks up in second half
Financial year 2023/24: Sonova ends year on improving trajectory after growth picks up in second half
Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024
Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024


Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution

Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 14, 2024
Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 14, 2024


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the BofA

QuidelOrtho Reports First Quarter 2024 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports First Quarter 2024 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and

Premier, Inc. Announces Cross-Industry Initiative to Improve Diagnosis and Care for Chronic Kidney Disease
Premier, Inc. Announces Cross-Industry Initiative to Improve Diagnosis and Care for Chronic Kidney Disease


Premier, Inc. (NASDAQ: PINC) is excited to announce a strategic partnership with AstraZeneca called Uncover CKD - Care Collective aiming to identify patients with undiagnosed clinical chronic

Inogen Announces First Quarter 2024 Financial Results
Inogen Announces First Quarter 2024 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31

STAAR Surgical Reports First Quarter 2024 Results
STAAR Surgical Reports First Quarter 2024 Results


STAAR Surgical Company (NASDAQ: K), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today